Visningssätt för begreppens/termernas förhållanden:
Det sätt begreppsrelationer visas:
Det sätt begreppsrelationer visas:
Tymosin
Hierarki: | ∟ ∟ ∟ ∟ Tymosin 125 sidobegrepp∟ ∟ ∟ ∟ ∟ Amyloid | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Lektiner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Peptoner | ∟ ∟ Prioner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Proteom | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Serpiner | ∟ Siden | ∟ ∟ ∟ ∟ ∟ ∟ ∟ TIMP | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Bombesin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leptin | ∟ Motilin | ∟ ∟ ∟ ∟ ∟ Relaxin | ∟ ∟ Sekretin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Tymosin 125 sidobegrepp∟ ∟ ∟ ∟ ∟ Amyloid | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Lektiner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Peptoner | ∟ ∟ Prioner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Proteom | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Serpiner | ∟ Siden | ∟ ∟ ∟ ∟ ∟ ∟ ∟ TIMP | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Bombesin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leptin | ∟ Motilin | ∟ ∟ ∟ ∟ ∟ Relaxin | ∟ ∟ Sekretin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Tymosin 125 sidobegrepp∟ ∟ ∟ ∟ ∟ Amyloid | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Lektiner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Peptoner | ∟ ∟ Prioner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Proteom | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Serpiner | ∟ Siden | ∟ ∟ ∟ ∟ ∟ ∟ ∟ TIMP | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Bombesin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leptin | ∟ Motilin | ∟ ∟ ∟ ∟ ∟ Relaxin | ∟ ∟ Sekretin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Tymosin 125 sidobegrepp∟ ∟ ∟ ∟ ∟ Amyloid | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Lektiner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Peptoner | ∟ ∟ Prioner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Proteom | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Serpiner | ∟ Siden | ∟ ∟ ∟ ∟ ∟ ∟ ∟ TIMP | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Bombesin | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Leptin | ∟ Motilin | ∟ ∟ ∟ ∟ ∟ Relaxin | ∟ ∟ Sekretin | ∟ ∟ ∟ ∟ |
Bredare villkor: | |
Anmärkning: | Glycoproteins (1973-1974) | Thymus Extracts (1974) | Thymus Gland (1973-1974) | Tissue Extracts (1973-1974)X |
Anmärkning: | Thymosin. A family of heat-stable, polypeptide hormones secreted by the thymus gland. Their biological activities include lymphocytopoiesis, restoration of immunological competence and enhancement of expression of T-cell characteristics and function. They have therapeutic potential in patients having primary or secondary immunodeficiency diseases, cancer or diseases related to aging.
X |
Annotation: | /biosyn /physiol permitted
X |
historyNote*: | 84(75); was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76
X |
publicMeSHNote*: | 84; was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76
X |
activeMeSHYear*: | 2007X |
dateCreated*: | 1974-11-19X |
dateEstablished*: | 1984-01-01X |
dateRevised*: | 2006-07-05X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | jmpX |
recordOriginator*: | NLMX |
Typ: | |
Samordna villkor: | |
URI: | |
Termer och motsvarande begrepp: | Tymosiini (fi) XThymosin (en) Thymosins (en, ersatt) |
Dela: |
Laddar resultat...